340B Contract Pharmacy Audits Double: HRSA Targets Compliance Gaps at FQHCs
HRSA has doubled 340B program audits targeting contract pharmacy arrangements, with 47 covered entities under review in Q1 2026. Common violations include duplicate discounts, inadequate patient eligibility verification, and missing contract pharmacy agreements. FQHCs operating 340B programs must demonstrate real-time eligibility checks, split-billing compliance, and complete audit trails for every 340B transaction. Non-compliance can result in program repayment and suspension.
Key takeaways
- HRSA doubled 340B audits: 47 covered entities under review in Q1 2026
- Common violations: duplicate discounts, inadequate eligibility verification, missing pharmacy agreements
- Non-compliance: program repayment and suspension
- Action: demonstrate real-time eligibility checks, split-billing compliance, complete audit trails
Primary source
HRSA Office of Pharmacy AffairsFQHC Talent. (2026, February 15). 340B Contract Pharmacy Audits Double: HRSA Targets Compliance Gaps at FQHCs. Primary source: HRSA Office of Pharmacy Affairs. Retrieved April 28, 2026, from https://www.fqhctalent.com/intel/340b-audit-wave-contract-pharmacy-2026
More in Risk & Compliance
Jul 5
Section 1557 Language Access Annual Notice Year 1 Anniversary — July 5, 2026 Compliance Window
May 11
URGENT: HHS Section 504 WCAG 2.1 AA Digital Accessibility Deadline Hits FQHCs May 11, 2026 — 3 Weeks Away
Apr 27
HRSA 340B Rebate Model ICR Burden Comment Window Closes April 27 — Second Window for FQHCs After April 20 Main Deadline
Apr 22
Section 504 / WCAG 2.1AA 'Red Alert' — Enforcement Interpretation May Be Contested in Final Weeks Before May 11